95 results
Page 4 of 5
6-K
EX-99.1
woi4o6w
26 Aug 20
Galapagos to present new insights in IPF and related clinical developments at the European Respiratory Society Congress
6:37am
6-K
EX-99.1
t7c pi374na
19 Aug 20
Current report (foreign)
6:00am
6-K
EX-99.1
0gfnuoafwix 72
13 Aug 20
Current report (foreign)
9:42am
6-K
EX-99.1
wpxrq5rd7vafkkv
24 Jul 20
Current report (foreign)
9:45am
6-K
EX-99.1
pambv7
8 Jun 20
Current report (foreign)
6:00am
6-K
EX-99.1
c0uu5fgvuc3 5og
4 Jun 20
Current report (foreign)
11:01am
6-K
EX-99.1
dupdto
26 May 20
Gilead and Galapagos Announce Positive Topline Results of Phase 2B/3 Trial of Filgotinib In Moderately to Severely Active Ulcerative Colitis
6:10am
6-K
EX-99.1
curoc544o kpi5
12 Nov 19
Current report (foreign)
6:15am
6-K
EX-99.1
lnx75f7ex9qoa
11 Oct 19
Gilead and Galapagos Announce Efficacy and Safety Results of Filgotinib Through 52 Weeks In Finch 1 and Finch 3 Studies In Rheumatoid Arthritis
6:00am
6-K
EX-99.1
h4g2359
5 Sep 19
European Medicines Agency Validates Marketing Application for Filgotinib for the Treatment of Rheumatoid Arthritis
5:24pm
6-K
EX-99.2
d4jh 8nv9p5rk
29 Aug 19
Gilead and Galapagos Complete Closing of Their Transformative Research and Development Collaboration
4:44pm
6-K
EX-99.1
tpsm8jhidi9ec1 yhc9
29 Aug 19
Gilead and Galapagos Complete Closing of Their Transformative Research and Development Collaboration
4:44pm
6-K
EX-99.4
vsg n0exowdv
29 Aug 19
Gilead and Galapagos Complete Closing of Their Transformative Research and Development Collaboration
4:44pm
6-K
EX-99.3
5bmizla0wpmxgfhk
29 Aug 19
Gilead and Galapagos Complete Closing of Their Transformative Research and Development Collaboration
4:44pm
6-K
EX-99.1
hdb ke9m56bukex
15 Jul 19
Gilead and Galapagos Enter into Transformative Research and Development Collaboration
11:59am
6-K
EX-99.1
wncbz7
31 May 19
Current report (foreign)
10:27am
F-3ASR
2ag3vi
29 Mar 19
Automatic shelf registration (foreign)
5:26pm
6-K
EX-99.1
080xtv91cwoqvd ien
29 Mar 19
Current report (foreign)
6:16am